(Q37873779)

24 August 2017

title

Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). (English)

1 reference

24 August 2017

0 references

acute coronary syndrome

1 reference

Chlamydia pneumoniae

1 reference

Chandra HR

1

1 reference

24 August 2017

Choudhary N

2

1 reference

24 August 2017

O'Neill C

3

1 reference

24 August 2017

Boura J

4

1 reference

24 August 2017

Timmis GC

5

1 reference

24 August 2017

O'Neill WW

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

American Journal of Cardiology

24 August 2017

published in

1 reference

24 August 2017

volume

88

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

214-218

1 reference

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

: Risk factors for seropositivity and association with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Infections, inflammation, and the risk of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Chronic infections and coronary heart disease: is there a link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Chlamydia pneumoniae and acute myocardial infarction in Jerusalem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Infections caused by Chlamydia pneumoniae strain TWAR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Chlamydia infections and heart disease linked through antigenic mimicry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Autoimmunity and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Molecular mediators of arterial inflammation: a role for microbial products?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Description and status of the azithromycin and coronary events study (ACES).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901628-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(01)01628-9

1 reference

24 August 2017

1 reference